Public CompanyDrug to treat swine flu to be available in retail mkt
The government today said it will allow the retail sale of "oseltamivir", the only medicine available to treat the swine flu virus "H1N1".
- JB Chemicals gets USFDA nod for its anti-allergic tablets - GSK to launch "promecta" in India by 2009-end - Aurobindo Pharma receives Swissmedic approval for cefepime for injection - Ranbaxy receives final USFDA approval for Glycopyrolate - SC pulls up Ranbaxy for delayed raising of refund issue - Hyderabad firm delivers anti-swine flu drug
Once a notification is issued, six companies are likely to get government nod to sell the drugs through pharmacy stores.\
"The notification regarding the sale of oseltamivir through retail pharmacies is expected to come in the next 10-12 days," Drug Controller General of India Surinder Singh told reporters on the sidelines of CII Life Lines Conclave.
Till now, six companies Ranbaxy, Cipla, Metco, Hetero, Strides and Roche have been granted licence for the manufacture and distribution of the drugs.
Oseltamivir is a generic version of Roche"s Tamiflu and the drug will be sold in the retail market under Schedule-X norms that cover the sale of drugs prepared using narcotics substances.
He also said till now six companies have applied for producing and developing swine flu vaccine in the country.